Literature DB >> 6097174

Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosis.

W H Beggs.   

Abstract

It was shown that tioconazole possesses an important property not shared by ketoconazole and miconazole, its well-known relatives in the imidazole group of antifungal drugs. At a concentration of 3.8 X 10(-5) M, tioconazole, like miconazole, caused rapid 2- to 3-log reductions in CFU per milliliter when added to late-logarithmic-phase Candida albicans or Candida parapsilosis cells. Only tioconazole, however, exerted similar reductions when added to diluted stationary-phase cultures. This growth-phase-independent lethal action has important clinical implications and may explain the superior performance of tioconazole, which was observed in earlier comparative drug studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097174      PMCID: PMC179998          DOI: 10.1128/AAC.26.5.699

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles.

Authors:  H Van den Bossche; G Willemsens; W Cools; P Marichal; W Lauwers
Journal:  Biochem Soc Trans       Date:  1983-12       Impact factor: 5.407

2.  Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use.

Authors:  E Lefler; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

3.  Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans.

Authors:  E M Johnson; M D Richardson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

Review 4.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

5.  Inhibition of sterol C14 demethylation by imidazole-containing antifungals.

Authors:  G W Pye; M S Marriott
Journal:  Sabouraudia       Date:  1982-12

6.  Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.

Authors:  M S Marriott; J R Baird; K W Brammer; J K Faulkner; G Halliwell; S Jevons; M H Tarbit
Journal:  Dermatologica       Date:  1983

7.  Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.

Authors:  M S Marriott
Journal:  J Gen Microbiol       Date:  1980-03

8.  Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1980-11       Impact factor: 5.790

9.  Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.

Authors:  S Jevons; G E Gymer; K W Brammer; D A Cox; M R Leeming
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

10.  Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release.

Authors:  J E Cope
Journal:  J Gen Microbiol       Date:  1980-07
View more
  3 in total

1.  Rapid fungicidal action of tioconazole and miconazole.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1987-03       Impact factor: 2.574

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.